SILVERNAIL LAUREN P
Insider CIK 1225755 · DVAX Director · HROW Director · RVNC CFO, Seretary & EVP Corp Dev. · EOLS See Remarks · HARP Director · ISTA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HROW HARROW, INC. | A Award deriv | 2026-06-18 | 2026-06-22 | 5,248 | — | $0 | 5,248 | SEC↗ |
| HROW HARROW, INC. | P Buy | 2026-05-18 | 2026-05-19 | 1,000 | $31.00 | $31.0K | 1,000 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 42,750 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer deriv | 2026-02-10 | 2026-02-10 | 7,125 | — | $0 | 0 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | D To issuer | 2026-02-10 | 2026-02-10 | 10,075 | — | $0 | 0 | SEC↗ |
| HROW HARROW, INC. | A Award deriv | 2025-06-20 | 2025-06-24 | 7,339 | — | $0 | 7,339 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-06-11 | 2025-06-13 | 7,125 | — | $0 | 7,125 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award | 2025-06-11 | 2025-06-13 | 1,439 | — | $0 | 10,075 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-03 | 2025-02-05 | 42,750 | — | $0 | 42,750 | SEC↗ |
| DVAX DYNAVAX TECHNOLOGIES CORP | A Award deriv | 2025-02-03 | 2025-02-05 | 8,636 | — | $0 | 8,636 | SEC↗ |
| HROW HARROW, INC. | A Award deriv | 2024-06-14 | 2024-06-17 | 8,347 | — | $0 | 8,347 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,300 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer deriv | 2024-03-11 | 2024-03-11 | 2,033 | — | $0 | 0 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | D To issuer | 2024-03-11 | 2024-03-11 | 5,000 | — | $0 | 0 | SEC↗ |
| HROW HARROW, INC. | A Award deriv | 2024-01-26 | 2024-01-30 | 3,119 | — | $0 | 3,119 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award | 2023-11-27 | 2023-11-28 | 5,000 | — | $0 | 5,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | A Award deriv | 2022-09-15 | 2022-09-19 | 20,335 | — | $0 | 20,335 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2022-05-18 | 2022-05-18 | 52,015 | $12.42 | $646.0K | 141,571 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2022-05-17 | 2022-05-18 | 16,189 | $13.92 | $225.4K | 193,586 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2022-03-08 | 2022-03-10 | 10,192 | $9.73 | $99.2K | 209,775 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2022-01-24 | 2022-01-26 | 77,640 | — | $0 | 77,640 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2022-01-24 | 2022-01-26 | 53,571 | — | $0 | 219,967 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-10 | 2021-08-12 | 14,293 | $11.18 | $159.8K | 194,982 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-08-10 | 2021-08-12 | 14,293 | $11.18 | $159.8K | 166,396 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2021-01-27 | 2021-02-01 | 90,000 | — | $0 | 180,689 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2021-01-25 | 2021-01-26 | 2,699 | $7.46 | $20.1K | 90,689 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2020-05-13 | 2020-05-15 | 40,000 | — | $0 | 93,388 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2020-01-23 | 2020-01-24 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2020-01-23 | 2020-01-24 | 26,000 | — | $0 | 53,388 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2019-05-31 | 2019-05-31 | 2,612 | $13.53 | $35.3K | 27,388 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2019-01-23 | 2019-01-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2018-05-29 | 2018-05-31 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2018-05-29 | 2018-05-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-24 | 2,874 | $30.25 | $86.9K | 65,497 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-22 | 2018-03-23 | 3,431 | $30.85 | $105.8K | 68,371 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-03-15 | 2018-03-15 | 1,152 | $31.65 | $36.5K | 71,802 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-13 | 2018-03-15 | 25,867 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-13 | 2018-03-15 | 25,867 | $34.50 | $892.4K | 72,954 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-13 | 2018-03-15 | 25,867 | $8.70 | $225.0K | 98,821 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-09 | 2018-03-09 | 10,000 | — | $0 | 25,867 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-09 | 2018-03-09 | 10,000 | $32.50 | $325.0K | 72,954 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-09 | 2018-03-09 | 10,000 | $8.70 | $87.0K | 82,954 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-07 | 2018-03-09 | 10,000 | — | $0 | 35,867 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-07 | 2018-03-09 | 10,000 | $31.50 | $315.0K | 72,954 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-07 | 2018-03-09 | 10,000 | $8.70 | $87.0K | 82,954 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-02-15 | 2018-02-16 | 1,136 | $31.75 | $36.1K | 72,954 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-02-08 | 2018-02-09 | 48,750 | — | $0 | 48,750 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-02-08 | 2018-02-09 | 8,125 | — | $0 | 74,090 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2018-01-28 | 2018-01-30 | 990 | $33.50 | $33.2K | 65,965 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2017-12-29 | 2018-01-03 | 443 | $22.99 | $10.2K | 66,955 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2017-12-26 | 2017-12-28 | 17,506 | — | $0 | 45,867 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2017-12-26 | 2017-12-28 | 17,506 | $8.70 | $152.3K | 66,512 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2017-11-07 | 2017-11-09 | 10,000 | — | $0 | 63,373 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2017-11-07 | 2017-11-09 | 10,000 | $8.70 | $87.0K | 59,006 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-11-07 | 2017-11-09 | 10,000 | $26.83 | $268.3K | 49,006 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-10-12 | 2017-10-16 | 11,164 | $26.67 | $297.7K | 49,006 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2017-06-30 | 2017-07-05 | 604 | $18.32 | $11.1K | 60,170 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2017-05-26 | 2017-05-31 | 23,000 | — | $0 | 73,373 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2017-05-26 | 2017-05-31 | 23,000 | $8.70 | $200.1K | 59,566 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2017-05-22 | 2017-05-24 | 1,793 | $20.20 | $36.2K | 36,566 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2017-03-16 | 2017-03-17 | 1,269 | $19.20 | $24.4K | 38,359 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2017-01-28 | 2017-01-30 | 1,063 | $20.00 | $21.3K | 39,628 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-01-26 | 2017-01-30 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-01-26 | 2017-01-30 | 10,000 | — | $0 | 40,691 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2016-06-30 | 2016-07-05 | 749 | $11.56 | $8.7K | 30,691 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2016-05-19 | 2016-05-23 | 1,753 | $17.11 | $30.0K | 29,942 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-02-02 | 2016-02-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2016-02-02 | 2016-02-04 | 10,000 | — | $0 | 31,695 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2016-01-28 | 2016-02-01 | 1,063 | $20.30 | $21.6K | 21,695 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2015-12-31 | 2016-01-04 | 339 | $27.00 | $9.2K | 22,758 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | J Other | 2015-06-30 | 2015-07-02 | 633 | $14.16 | $9.0K | 633 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | F Tax w/h | 2015-05-19 | 2015-05-21 | 1,753 | $25.94 | $45.5K | 21,517 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-01-28 | 2015-01-30 | 41,310 | — | $0 | 41,310 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2015-01-28 | 2015-01-30 | 7,290 | — | $0 | 23,270 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2014-12-11 | 2014-12-15 | 200 | $17.73 | $3.5K | 14,200 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2014-12-11 | 2014-12-15 | 780 | $17.74 | $13.8K | 14,980 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-05-19 | 2014-05-21 | 43,000 | — | $0 | 43,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2014-05-19 | 2014-05-21 | 14,000 | $32.22 | $451.1K | 14,000 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 22,125 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 5,834 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 14,166 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 22,697 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 22,283 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 8,814 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 3,141 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 20,564 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 21,396 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 25,542 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 122,875 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 99,133 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer deriv | 2012-06-06 | 2012-06-15 | 5,875 | — | $0 | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer | 2012-06-06 | 2012-06-15 | 187,141 | $9.10 | $1.70M | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 2,212 | $9.08 | $20.1K | 25,542 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 13,717 | $9.08 | $124.6K | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 16,649 | $9.08 | $151.2K | 8,814 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 65,867 | $9.08 | $598.1K | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 17,203 | $9.08 | $156.2K | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 11,262 | $9.08 | $102.3K | 20,564 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise deriv | 2012-05-08 | 2012-05-10 | 18,903 | $9.08 | $171.6K | 0 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 18,903 | $4.46 | $84.3K | 138,687 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 9,285 | $9.08 | $84.3K | 129,402 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 65,867 | $5.40 | $355.7K | 195,269 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 39,172 | $9.08 | $355.7K | 156,097 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 17,203 | $6.77 | $116.5K | 173,300 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 12,826 | $9.08 | $116.5K | 160,474 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 13,717 | $7.43 | $101.9K | 174,191 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 11,224 | $9.08 | $101.9K | 162,967 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 16,649 | $1.04 | $17.3K | 179,616 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 1,907 | $9.08 | $17.3K | 177,709 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 1,661 | $9.08 | $15.1K | 185,020 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 2,212 | $6.82 | $15.1K | 186,681 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | F Tax w/h | 2012-05-08 | 2012-05-10 | 4,502 | $9.08 | $40.9K | 184,469 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | M Exercise | 2012-05-08 | 2012-05-10 | 11,262 | $3.63 | $40.9K | 188,971 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer | 2012-02-08 | 2012-02-09 | 1,066 | $8.15 | $8.7K | 119,784 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer | 2012-02-07 | 2012-02-09 | 1,146 | $8.17 | $9.4K | 120,850 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer | 2012-02-03 | 2012-02-06 | 942 | $8.22 | $7.7K | 121,996 | SEC↗ |
| ISTA ISTA PHARMACEUTICALS INC | D To issuer | 2012-02-02 | 2012-02-06 | 942 | $8.18 | $7.7K | 122,938 | SEC↗ |